- United Kingdom
- /
- Chemicals
- /
- AIM:ITX
3 UK Penny Stocks With Market Caps Under £200M
Reviewed by Simply Wall St
The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid concerns over weak trade data from China. Despite these broader market pressures, investors may find intriguing opportunities in penny stocks—typically smaller or newer companies that offer potential growth at lower price points. Although the term "penny stock" might seem outdated, these investments remain relevant today as they can present hidden value when backed by strong financials and sound fundamentals.
Top 10 Penny Stocks In The United Kingdom
Name | Share Price | Market Cap | Financial Health Rating |
Polar Capital Holdings (AIM:POLR) | £4.85 | £467.47M | ★★★★★★ |
ME Group International (LSE:MEGP) | £2.20 | £828.88M | ★★★★★★ |
Supreme (AIM:SUP) | £1.74 | £202.9M | ★★★★★★ |
FRP Advisory Group (AIM:FRP) | £1.415 | £347M | ★★★★★★ |
Next 15 Group (AIM:NFG) | £3.9644 | £394.28M | ★★★★☆☆ |
Stelrad Group (LSE:SRAD) | £1.48 | £188.48M | ★★★★★☆ |
Luceco (LSE:LUCE) | £1.328 | £204.82M | ★★★★★☆ |
Tristel (AIM:TSTL) | £4.20 | £200.13M | ★★★★★★ |
Character Group (AIM:CCT) | £2.80 | £52.57M | ★★★★★★ |
Integrated Diagnostics Holdings (LSE:IDHC) | $0.4745 | $275.84M | ★★★★★★ |
Click here to see the full list of 472 stocks from our UK Penny Stocks screener.
Let's dive into some prime choices out of the screener.
Itaconix (AIM:ITX)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Itaconix plc, with a market cap of £19.55 million, develops plant-based polymers for home and personal care applications in North America and Europe.
Operations: The company generates revenue from two main segments: Formulation Solutions, contributing $1.51 million, and Performance Ingredients, accounting for $5.10 million.
Market Cap: £19.55M
Itaconix plc, with a market cap of £19.55 million, focuses on plant-based polymers and has faced challenges with declining sales, reporting US$2.78 million for the first half of 2024 compared to US$4.03 million the previous year. Despite being unprofitable and having a negative return on equity (-18.4%), Itaconix is debt-free and maintains sufficient cash runway for over a year based on current free cash flow trends. The company is leveraging its seasoned management team to drive innovation through initiatives like the SPARX program, aiming to introduce new sustainable products in collaboration with industry partners by 2025.
- Take a closer look at Itaconix's potential here in our financial health report.
- Gain insights into Itaconix's outlook and expected performance with our report on the company's earnings estimates.
Knights Group Holdings (AIM:KGH)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Knights Group Holdings plc, with a market cap of £104.82 million, operates in the United Kingdom offering legal and professional services through its subsidiaries.
Operations: The company generates revenue of £149.96 million from its legal and professional services segment.
Market Cap: £104.82M
Knights Group Holdings plc, with a market cap of £104.82 million, shows potential despite some challenges. The stock trades at a significant discount to its estimated fair value and offers good relative value compared to peers. Over the past five years, earnings have grown substantially at 29.8% annually, although recent growth has slowed to 24%. Debt management is prudent with a reduced debt-to-equity ratio and well-covered interest payments by profits. However, short-term assets do not fully cover long-term liabilities, and recent financial results were impacted by a one-off loss of £6.9 million affecting earnings quality.
- Jump into the full analysis health report here for a deeper understanding of Knights Group Holdings.
- Learn about Knights Group Holdings' future growth trajectory here.
Spectra Systems (AIM:SPSY)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Spectra Systems Corporation invents, develops, and sells integrated optical systems both in the United States and internationally, with a market cap of £122.02 million.
Operations: The company's revenue is primarily derived from its Authentication Systems segment, excluding banknote cleaning, which generated $21.66 million, followed by Secure Transactions at $1.92 million.
Market Cap: £122.02M
Spectra Systems Corporation, with a market cap of £122.02 million, demonstrates mixed performance indicators in the penny stock category. The company reported significant revenue growth for the first half of 2024, reaching US$22.74 million compared to US$11.62 million the previous year, with net income rising to US$5.25 million. Despite this growth, earnings have declined by 19.8% over the past year and profit margins decreased from 37.3% to 21%. While short-term assets exceed liabilities and debt is well covered by operating cash flow, shareholders experienced dilution with a 7% increase in shares outstanding last year.
- Navigate through the intricacies of Spectra Systems with our comprehensive balance sheet health report here.
- Assess Spectra Systems' future earnings estimates with our detailed growth reports.
Taking Advantage
- Discover the full array of 472 UK Penny Stocks right here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About AIM:ITX
Itaconix
Engages in the development of plant-based polymers for home and personal care applications in North America and Europe.
Flawless balance sheet low.